Biocompatible ionic liquids and their applications in pharmaceutics
Ionic liquids (ILs) have been used as solvents or materials, or both, in many applications,
including pharmaceutics and medicine due to their exceptional properties consisting of the …
including pharmaceutics and medicine due to their exceptional properties consisting of the …
The role of ionic liquids in the pharmaceutical field: An overview of relevant applications
SN Pedro, CS R. Freire, AJD Silvestre… - International journal of …, 2020 - mdpi.com
Solubility, bioavailability, permeation, polymorphism, and stability concerns associated to
solid-state pharmaceuticals demand for effective solutions. To overcome some of these …
solid-state pharmaceuticals demand for effective solutions. To overcome some of these …
Flexible and robust bacterial cellulose‐based ionogels with high thermoelectric properties for low‐grade heat harvesting
K Liu, J Lv, G Fan, B Wang, Z Mao… - Advanced Functional …, 2022 - Wiley Online Library
The utilization of low‐grade and abundant thermal sources based on thermoelectric (TE)
materials is crucial for the development of a sustainable society. However, high …
materials is crucial for the development of a sustainable society. However, high …
Surface functionalization of MXene with chitosan through in-situ formation of polyimidazoles and its adsorption properties
G Yang, X Hu, J Liang, Q Huang, J Dou, J Tian… - Journal of Hazardous …, 2021 - Elsevier
In this work, a novel imidazoles-MXene hybrid composite, namely polyimidazoles chain
overlaying on the surface of MXene (Ti 3 C 2@ IMIZ), was prepared by a simple method …
overlaying on the surface of MXene (Ti 3 C 2@ IMIZ), was prepared by a simple method …
Ionic liquid transdermal delivery system: Progress, prospects, and challenges
B Lu, T Liu, H Wang, C Wu, H Chen, Z Liu… - Journal of Molecular …, 2022 - Elsevier
In the drug delivery system, the transdermal drug delivery system has the advantages of
painless administration, avoiding the first-pass metabolism, sustained therapeutic effect, and …
painless administration, avoiding the first-pass metabolism, sustained therapeutic effect, and …
Biotech nanocellulose: A review on progress in product design and today's state of technical and medical applications
D Klemm, K Petzold-Welcke, F Kramer, T Richter… - Carbohydrate …, 2021 - Elsevier
Biotech nanocellulose (bacterial nanocellulose, BNC) is a high potential natural polymer.
Moreover, it is the only cellulose type that can be produced biotechnologically using …
Moreover, it is the only cellulose type that can be produced biotechnologically using …
Biocompatible ionic liquid surfactant-based microemulsion as a potential carrier for sparingly soluble drugs
Develo** a universal drug delivery vehicle of sparingly soluble drugs remains a
challenge, with surface-active ionic liquid (SAIL)-based ionic liquid-in-oil (IL/O) …
challenge, with surface-active ionic liquid (SAIL)-based ionic liquid-in-oil (IL/O) …
Recent development of nanomaterials for transdermal drug delivery
Nano-engineered medical products first appeared in the last decade. The current research
in this area focuses on develo** safe drugs with minimal adverse effects associated with …
in this area focuses on develo** safe drugs with minimal adverse effects associated with …
The emerging role of ionic liquid-based approaches for enhanced skin permeation of bioactive molecules: a snapshot of the past couple of years
Topical and transdermal delivery systems are of undeniable significance and ubiquity in
healthcare, to facilitate the delivery of active pharmaceutical ingredients, respectively, onto …
healthcare, to facilitate the delivery of active pharmaceutical ingredients, respectively, onto …
Ionic liquids: Formulation avenues, drug delivery and therapeutic updates
NR Jadhav, SP Bhosale, SS Bhosale, SD Mali… - Journal of Drug Delivery …, 2021 - Elsevier
Background Numerous challenges are faced during formulation and biopharmaceutics of
newly developed drug molecules due to polymorphic conversion, poor bioavailability …
newly developed drug molecules due to polymorphic conversion, poor bioavailability …